The beneficial effect of fish oil on the idiopathic hypercalciuria in children


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

OBJECTIVE. EVALUATION OF THE EFFECTIVENESS OF THE USE OF FISH OIL PREPARATIONS IN CHILDREN WITH HYPERCALCIURIA. MATERIAL AND METHODS. THE STUDY INCLUDED 27 CHILDREN AGED 3 TO 10 YEARS (MEFN AGE 6.0±2.23 YEARS) WITH DETECTED HYPERCALCIURIA ACCORDING TO THE CALCIUM-CREATININE COEFFICIENT IN URINE ABOVE 0.6 MMOL/MMOL, WITH NORMAL PLASMA CALCIUM AND PARATHYROID HORMONE LEVELS. GENEALOGICAL HISTORY WAS ANALYZED; SOMATIC STATUS ASSESSMENT, GENERAL CLINICAL AND BIOCHEMICAL STUDIES OF BLOOD AND URINE SAMPLES WITH DETERMINATION OF THE CONTENT OF CALCIUM AND CREATININE IN THE URINE TO CALCULATE THE CALCIUM-CREATININE COEFFICIENT. TO ASSESS THE STATE OF THE ORGANS OF THE URINARY SYSTEM, INSTRUMENTAL METHODS OF DIAGNOSIS WERE USED. RESULTS. ANOMALIES IN THE DEVELOPMENT OF THE URINARY SYSTEM WERE REVEALED IN 62.9% OF CHILDREN WITH HYPERCALCIURIA; 22.2% OF PATIENTS HAD a URINARY TRACT INFECTION, AND 1 8.5% HAD NEUROGENIC URINATION DISORDERS. MORE THAN HALF (59.3%) OF CHILDREN WITH HYPERCALCIURIA HAD BURDENED FAMILIAL HISTORY OF UROLITHIASIS. CLINICALLY, IN THE CHILDREN EXAMINED DYSURIC (48.1%) AND PAINFUL (18.5%) SYNDROMES WERE IDENTIFIED. OXALURIA WAS REGISTERED IN THE URINARY SEDIMENT IN 29.6% OF THE CHILDREN, AND MICROHEMATURIA IN 18.5%. 48.1% OF PATIENTS SUFFERED HYPERSTENURIA. ALL CHILDREN WITH HYPERCALCIURIA PRESCRIBED FISH OIL AT A DAILY DOSE OF 1000 MG FOR PRESCHOOL CHILDREN AND 1500 MG FOR SCHOOLCHILDREN. THE COURCE OF THERAPY WAS 3 MONTHS. EVALUATION OF CLINICAL AND LABORATORY MANIFESATIONS AFTER 3 MONTHS OF THERAPY SHOWED A SIGNIFICANT INCREASE IN THE DAILY VOLUME OF URINE IN A NUMBER OF CHILDREN, WHICH WAS ACCOMPANIED BY A DECREASE IN ITS SPECIFIC WEIGHT. RED BLOOD CELLS WERE NOT DETECTED IN THE FIELD OF VISION IN URINE TESTS IN 60% OF CHILDREN WITH PREVIOUS HEMATURIA AFTER 3 MONTHS. THE CALCIUM-CREATININE COEFFICIENT WAS NORMALIZED IN 14 (51.9%) PATIENTS. CONCLUSION. THE USE OF FISH OIL PREPARATIONS FOR 3 MONTHS AT A DOSE OF 1000-1500 mg CONTRIBUTES TO THE DISAPPEARANCE OF SYMPTOMS OF IDIOPATHIC HYPERCALCIURIA AND THE NORMALIZATION OF URINE CALCIUM EXCRETION IN MORE THAN 50% OF CHILDREN.

Full Text

Restricted Access

About the authors

N. M Mikheeva

FSBEI HE "Altai State Medical University" of RMH

Email: micheeva.1974@mail.ru
PhD in Medical Sciences, Associate Professor at the Department of Propaedeutics of Children 's Diseases

Ya. F Zverev

FSBEI HE "Altai State Medical University" of RMH

Doctor of Medical Sciences, Professor at the Department of Pharmacology

G. I Vykhodtseva

FSBEI HE "Altai State Medical University" of RMH

Doctor of Medical Sciences, Professor, Head of the Department of Pediatrics with the Course of FPE

Yu. F Lobanov

FSBEI HE "Altai State Medical University" of RMH

Doctor of Medical Sciences, Professor, Head of the Department of Propaedeutics of Children 's Diseases

References

  1. Srivastava Т., Schwaderer A. Diagnosis and management of hypercalciuria in children. Curr.Opin.Pediatr. 2009; 21(2): 214-219.
  2. Wrôblewski T., Wystrychowskî A. Hypercalciuria. Przegl. Lek. 2011; 68(2): 107-113.
  3. Михеева Н.М., Зверев Я.Ф., Выходцева Г.И. Современные представления об этиологии и патогенезе идиопатической гиперкальциурии. Нефрология. 2015; 19(4): 29-40.
  4. Михеева H.M., Выходцева Г.И., Зверев Я.Ф., Лобанов Ю.Ф. Особенности течения идиопатической гиперкальциурии у детей. Анализ клиниколабораторных проявлений. Нефрология. 2017; 21(4): 68-72.
  5. Parekh D.J., Pope J.C. 4th, Adams M.C., Brock J.W. 3rd. The association of an increased urinary calcium-to-creatinine ratio and asymptomatic gross and microscopic hematuria in children. J. Urol. 2002; 167(l): 272-274.
  6. Михеева H.M., Зверев Я.Ф., Выходцева Г.И. Гиперкалъциурия у детей с инфекцией мочевой системы. Нефрология. 2014; 18(1): 74-79. [Mikheyeva N.M., Vykhodtseva G.I., Zverev YA.F., Lobanov YU.F. Hypercaiciuria in children with urinary tract infectionNefrologiya. 2014; 18(l): 74-79. (In Russ.)[.
  7. Михеева H.M., Текутьева H.A., Зверев Я.Ф., Выходцева Г.И., Лобанов Ю.Ф. Идиопатическая гиперкалъциурия и нейрогенные расстройства мочеиспускания у детей г. Барнаула. Клиническая нефрология. 2013; 5: 42-44.
  8. Михеева H.M., Зверев Я.Ф., Выходцева Г.И., Лобанов Ю.Ф. Персистирующая гематурия как частое проявление идиопатической гиперкальциурии у детей. Клиническая нефрология. 2014; 5: 42-44.
  9. Liern M., Bohorquez M., Vallejo G. Treatment of idiopathic hypercaiciuria and its impact on associated diseases. Arch. Argent. Pediatr. 2013; lll(2),pii: S0325-00752013000200005. doi: 10.1590/S0325-00752013000200005.
  10. Nouvenne A., Meschi T., Prati B., Guerra A., Allegri F., Vezzoli G., Soldati L., Gambaro G., Maggiore U., Borghi L. Effect of a low-salt diet on idiopathic hypercaiciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am. J. GinNutr. 2010; 91(3): 565-570.
  11. Михеева H.M., Зверев Я.Ф., Выходцева F.H., Лобанов Ю.Ф. Эффективность диетотерапии в лечении идиопатической гиперкальциурии у детей. Российский педиатрический журнал. 2016; 19(2): 81-85.
  12. Borghi L., Schianchi T., Meschi T., Guerra A., Allegri F., Maggiore U., Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercaiciuria. N. Engl. J. Med. 2002; 346(ll): 77-84.
  13. Périmenis P., Wémeau J.L., Vantyghem M. C. Hypercaiciuria. Ann Endocrinol. (Paris). 2005; 66(6): 532-539.
  14. US Institute of Medicine. Strategies to Reduce Sodium Intake in the United States. National Academy of Sciences 2010. http.//www.iom.edu/Reports/2010/.
  15. Brown I.J., Tzoulaki I., Candeias V., Elliott P. Salt intakes around the world: implications for public health. Int. J. Epidemiol. 2009; 183: 1151-1156.
  16. Buck A.C., Davies R.L., Harrison T. The protective role of eicosapentaenoic acid (EPA) in the pathogenesis of nephrolithiasis. J. Urol. 1991; 146: 188-194.
  17. Rothwell P.J., Green R., Blacklock N.J., Kavanagh J.P. Does fish oil benefit stone formers? J. Urol. 1993; 150: 1391-1394.
  18. Baggio D., Budakovic A., Nassuato A., Vezzoli G., Manzato E., Luisetto G., Zaninotto M. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis. Kidney Int. 2000; 58(3): 1278-1284.
  19. Konya E., Tsuji H., Umekawa T., Kurita T., Iguchi M. Effect of ethyl icosapentate on urinary calcium and oxalate excretion. Int. J. Urol. 2000; 7: 361-365.
  20. Yasui T., Tanaka H., Fujita K., Iguchi M., Kohri K. Effects of eicosapentaenoic acid on urinary calcium excretion in calcium stone formers. Eur. Urol. 2001; 39: 580-585.
  21. Gambaro G., Checchetto S., Bacelle L. Dietary polyunsaturated fatty acids and idiopathic calcium nephrolithiasis. In: Jüngers P., Daudon M., eds. Proceedings of the 7th European Symposium on Urolithiasis. Paris, 1997; 88.
  22. Ortiz-Alvarado 0., Miyaoka R., Kriedberg C., Leavitt D.A., Moeding A., Stessman M., Monga M. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid in the management of hypercalciuric stone formers. Urology. 2012; 7(2): 282-286.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies